4.びまん性汎細気管支炎とマクロライドの新作用

工藤 翔二

doi:10.2169/naika.93.Suppl_57

[title in Japanese]

[in Japanese]

Author information

Keywords: DPB

JOURNAL FREE ACCESS

2004 Volume 93 Issue Suppl Pages 57-60

DOI https://doi.org/10.2169/naika.93.Suppl_57

Details

Published: February 20, 2004 Received: - Available on J-STAGE: June 12, 2008 Accepted: - Advance online publication: - Revised: -
Correction information
Date of correction: June 12, 2008 Reason for correction: - Correction: CITATION Details: Wrong : 2) Homma H, et al: Diffuse Panbronchiolitis: A disease of the transitional zone of the lung, Chest 83: 63, 1983.
6) Sugiyama Y, et al: Analysis of HLA antigen in patients with diffuse panbronchiolitis. Am Rev Respir Dis 141: 1459, 1990.
8) Keicho N, et al: Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. Am J Respir Crit Care Med 158: 846-850, 1998.
9) Park MH, et al: Association of HLA class I antigens with diffuse panbronchiolitis in Koreans. Am J Respir Crit Care Med 159: 526-529, 1999.
10) Keicho N, et al: Fine localization of a major diseasesusceptibility locus for diffuse panbronchiolitis. Am J Hum Genet 66(2): 501-507, 2000.
13) Kudoh S, et al: Improvement of survival inpatients with diffuse panbronchiolitis. Am J Respir Critic Care Med 157: 1829-1832, 1998.
14) Kudoh S: Erythromycin treatment in diffuse panbronchiolitis. Current Opini Pulm Med 4: 116-121, 1998.
15) Keicho N, Kudoh S: Diffuse panbronchiolitis-Role of macrolides in Therapy. Am J Respir Med 1: 119-131, 2002.
16) Tamaoki J, et al: Erythromycin inhibits Cl secretion across canine tracheal epitherial cells. Eur Respir J 5: 234-238, 1992.
17) Kadota J, et al: Amechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 147: 153-1599, 1993.
18) Takizawa H. et al: Erythromycin Modulates IL-8 Expression in Human Bronchial Epithelial Cells: Studies with Normal and Inflamated Airway Epithelium. Am J Respir Crit Care Med 156: 266-271, 1997.
19) Desaki M, et al: Erythromycin suppresses nuclear factorkappaB and activator protein-1 activation in human bronchial epithelial cells. Biochemical & Biophysical Research Communications 267: 124-820, 2000.
20) Tateda K, et al: Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45: 1930-1933, 2001.
21) Li Y, et al: Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice. Chest 122: 2137-2145, 2002.
22) Kudoh S, et al: Novel activity of Erythromycin and its derivatives. Omura S. ed. Mcarolide Antibiotics, 2nd ed. Academic Press. 533-569. 2002.

Right : 2) Homma H, et al: Diffuse Panbronchiolitis: A disease of the transitional zone of the lung, Chest 83: 63, 1983.
6) Sugiyama Y, et al: Analysis of HLA antigen in patients with diffuse panbronchiolitis. Am Rev Respir Dis 141: 1459, 1990.
8) Keicho N, et al: Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis. Am J Respir Crit Care Med 158: 846-850, 1998.
9) Park MH, et al: Association of HLA class I antigens with diffuse panbronchiolitis in Koreans. Am J Respir Crit Care Med 159: 526-529, 1999.
10) Keicho N, et al: Fine localization of a major diseasesusceptibility locus for diffuse panbronchiolitis. Am J Hum Genet 66(2): 501-507, 2000.
13) Kudoh S, et al: Improvement of survival inpatients with diffuse panbronchiolitis. Am J Respir Critic Care Med 157: 1829-1832, 1998.
14) Kudoh S: Erythromycin treatment in diffuse panbronchiolitis. Current Opini Pulm Med 4: 116-121, 1998.
15) Keicho N, Kudoh S: Diffuse panbronchiolitis-Role of macrolides in Therapy. Am J Respir Med 1: 119-131, 2002.
16) Tamaoki J, et al: Erythromycin inhibits Cl secretion across canine tracheal epitherial cells. Eur Respir J 5: 234-238, 1992.
17) Kadota J, et al: Amechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 147: 153-1599, 1993.
18) Takizawa H. et al: Erythromycin Modulates IL-8 Expression in Human Bronchial Epithelial Cells: Studies with Normal and Inflamated Airway Epithelium. Am J Respir Crit Care Med 156: 266-271, 1997.
19) Desaki M, et al: Erythromycin suppresses nuclear factor-kappaB and activator protein-1 activation in human bronchial epithelial cells. Biochemical & Biophysical Research Communications 267: 124-820, 2000.
20) Tateda K, et al: Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 45: 1930-1933, 2001.
21) Li Y, et al: Fourteen-membered ring macrolides inhibit vascular cell adhesion molecule 1 messenger RNA induction and leukocyte migration: role in preventing lung injury and fibrosis in bleomycin-challenged mice. Chest 122: 2137-2145, 2002.
22) Kudoh S, et al: Novel activity of Erythromycin and its derivatives. Omura S. ed. Mcarolide Antibiotics, 2nd ed. Academic Press. 533-569. 2002.

Date of correction: June 12, 2008 Reason for correction: - Correction: PDF FILE Details: -

Corresponding author

Correction information

Register with J-STAGE for free!